Connect with us

coronavirus

Ireland recommends temporary deferral of Astrazeneca COVID-19 vaccine

SHARE:

Published

5 years ago

on

We use your sign-up to provide content in ways you've consented to and to improve our understanding of you. You can unsubscribe at any time.

Ireland’s National Immunisation Advisory Committee recommended the temporary deferral of AstraZeneca’s COVID-19 vaccine on Sunday (14 March) following new information received from the Norwegian Medicines Agency, the country’s health ministry said, writes Padraic Halpin.

Three health workers in Norway who had recently received the AstraZeneca COVID-19 vaccine are being treated in hospital for bleeding, blood clots and a low count of blood platelets, its health authorities said on Saturday (13 March).

AstraZeneca vaccinations make up almost 20% of the 570,000 shots administered in Ireland, mainly to healthcare workers after its use was not initially recommended for those over 70. The advisory committee said it acted as a precaution, pending the receipt of more information and would meet later on Sunday.

Share this article:

Share this:
Related Topics:
EU Reporter publishes articles from a variety of outside sources which express a wide range of viewpoints. The positions taken in these articles are not necessarily those of EU Reporter. Please see EU Reporter’s full Terms and Conditions of publication for more information EU Reporter embraces artificial intelligence as a tool to enhance journalistic quality, efficiency, and accessibility, while maintaining strict human editorial oversight, ethical standards, and transparency in all AI-assisted content. Please see EU Reporter’s full A.I. Policy for more information.
Advertisement

Trending